Dmso (Topical) for Anti-Inflammatory

Research suggests that topical DMSO possesses anti-inflammatory properties supported by a modest but consistent body of evidence, including a 2016 laboratory and animal study finding that DMSO reduced inflammatory cytokines and prostaglandins in human blood samples and meaningfully reduced joint inflammation in a mouse arthritis model, and a 2023 narrative review concluding that DMSO's membrane-penetrating ability combined with its anti-inflammatory and antioxidant activity warrants further investigation for a range of skin and tissue conditions. The available evidence base consists primarily of reviews, preclinical studies, and animal models rather than large randomized controlled trials in humans, which limits the strength of conclusions that can be drawn. Several of the linked studies address topical anti-inflammatory treatments more broadly — particularly topical NSAIDs like diclofenac — and while these are not directly about DMSO, they provide context suggesting that topically delivered anti-inflammatory agents can achieve meaningful local effects with lower systemic exposure than oral alternatives. Overall, the research indicates DMSO shows genuine biological anti-inflammatory activity, but the human clinical evidence remains limited and more rigorous trials would be needed to draw firm conclusions about its effectiveness and safety for this purpose.